PlainPharmaWatch

CMS Open Payments · Tool

Beckman Coulter, Inc. vs Lightforce Orthodontics, Inc.

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Beckman Coulter, Inc. has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 2,954, versus 551 for the other company. Its single largest recorded recipient represents 0.5% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Beckman Coulter, Inc.
HHI 2,954 · top recipient 0.5%
Ranked #574 of 1,838 companies by HHI
Lightforce Orthodontics, Inc.
HHI 551 · top recipient 0.1%
Ranked #1,259 of 1,838 companies by HHI

Payment Overview

Total Payments
$8.3M
% of Industry
0.1%
Transactions
540
Avg per Transaction
$15.4K
Recipients
469
Avg per Recipient
$17.7K
Payment Types
5
Top Payment Type
Royalty or License
Total Payments
$8.3M
% of Industry
0.1%
Transactions
2,709
Avg per Transaction
$3.1K
Recipients
2,676
Avg per Recipient
$3.1K
Payment Types
4
Top Payment Type
Consulting Fee

Highlighted values indicate the higher figure for each metric.

Total payments compared

Beckman Coulter, Inc. vs Lightforce Orthodontics, Inc. - total reported payments in CMS Open Payments PY2024

Beckman Coulter, Inc.$8.3MLightforce Orthodontics, In…$8.3M

Payment Types Breakdown

Beckman Coulter, Inc.

Royalty or License $3.7M

44.8%

Consulting Fee $786.3K

9.5%

Compensation for Faculty or Speaker (Medical Education) $41.6K

0.5%

Travel and Lodging $37.3K

0.4%

Food and Beverage $10.6K

0.1%

Lightforce Orthodontics, Inc.

Consulting Fee $179.9K

2.2%

Education $171.7K

2.1%

Food and Beverage $122.1K

1.5%

Compensation for Services Other Than Consulting $37.6K

0.5%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Beckman Coulter, Inc.

  1. 1

    JOHN MICHAEL PESANDO

    $2,242,656.63 · 2 txns

  2. 2

    Dana-Farber Cancer Institute

    $1,041,340.38 · 5 txns

  3. 3

    Robert Wood Johnson University Hospi

    $211,740.24 · 2 txns

  4. 4

    Massachusetts General Hospital

    $211,740.24 · 2 txns

  5. 5

    BRIAN HARVEY

    $106,500.00 · 5 txns

Lightforce Orthodontics, Inc.

  1. 1

    JACQUELYN RAE SCHIECK

    $71,607.34 · 40 txns

  2. 2

    ALEXANDER WALDMAN

    $57,743.76 · 34 txns

  3. 3

    MOHAMMAD R RAZAVI

    $40,585.57 · 12 txns

  4. 4

    BRYAN ALLEN LOCKHART

    $39,120.58 · 17 txns

  5. 5

    TODD WELSH

    $25,890.41 · 40 txns

Summary Comparison

Metric Beckman Coulter, Inc. Lightforce Orthodontics, Inc.
Total Payments $8.3M $8.3M
% of Industry Total 0.1% 0.1%
Transaction Count 540 2,709
Avg per Transaction $15.4K $3.1K
Recipient Count 469 2,676
Avg per Recipient $17.7K $3.1K
Payment Type Count 5 4
Top Payment Type Royalty or License Consulting Fee

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.